Ind-Swift Laboratories informs about disclosures
Ind-Swift Laboratories has informed that it enclosed disclosures received under Regulation 29(2) of SEBI (Substantial acquisition of Shares and Takeover) Regulations, 2011 received by the Company on 21st April, 2026 from HCP Investments.
The above information is a part of company’s filings submitted to BSE.
